• ArkonTM (510(k) clearance pending) – High-performance anesthesia delivery system designed to work the way anesthesiologists work – so that the focus is on the patient, not the machine
• XprezzonTM – Patient monitoring system that delivers innovative technology and design to shape the new age of care for clinicians and patients alike
• ICS XprezzTM – Mobile app for iPad providing clinicians with up-to-the-minute views of waveform or numeric data in the palms of their hands
• Pathfinder® SL – Holter analysis solution that delivers innovative technology, rapid analysis and enhanced accuracy in the exploration of a patient’s cardiac condition
• Multigas Module – incorporating the PHASEIN gas analysis bench and NOMOLINETM (no-moisture) gas sampling line, for increased performance and reliability in monitoring CO2, N2O, O2 and anesthetic agents on all patient populations, from newborn through adult
“MEDICA provides an optimal venue to share our latest technology with healthcare providers worldwide,” said Nicholas Ong, President of Spacelabs Healthcare.
]]>“It is gratifying to know that users of our Holter monitoring solutions rank us highest in every category”, said Nicholas Ong, President of Spacelabs Healthcare. “This indicates to me that we are achieving our mission, which is to inspire the world to bring the best care experience to patient and families, one patient, one family, one smile at a time.”
Spacelabs Healthcare (as Delmar Reynolds) invented Holter technology more than 40 years ago. Today Spacelabs Healthcare offers a full line of non-invasive diagnostic cardiology solutions – from state-of-the-art 7 day Holter recorders and analyzers – to Cardiology Information Management Systems that coordinate and store results from a range of non-invasive procedures.
]]>“Spacelabs’ new Multigas Module provides clinicians with the information they need – quickly, accurately and reliably – to provide all of their patients, from infants to adults, with the very best patient care”, said Nicholas Ong, President of Spacelabs Healthcare.
]]>Spacelabs Healthcare’s accurate, reliable, and easy-to-use patient monitoring and connectivity solutions offer fast access to comprehensive patient information when and where needed to support decisions which, in turn, can improve response time, advance patient care, and enhance patient safety. For instance, clinicians on the go can have complete access to patient information including near-live waveforms and graphical trends on their iPads or other mobile devices thanks to ICS Xprezz, Spacelabs Healthcare’s new mobile app for iPad.
“Novation has our ongoing commitment to provide innovative technologies that help improve efficiencies, increase profitability, and enhance patient outcomes for the members it serves,” said Nicholas Ong, President of Spacelabs Healthcare.
“Our goal is to help anesthesiologists achieve that perfect balance between practice and patient, by providing tools that are intuitive and flexible so that their focus can always be on the patient,” said Nicholas Ong, President of Spacelabs Healthcare.
Spacelabs Healthcare has a rich history of innovation in the perioperative environment. Over the years, the company has introduced many “firsts”, such as the first anesthesia ventilator to integrate spirometry loops and the first maintenance-free vaporizer. Today, Spacelabs Healthcare’s perioperative research and development center, based in Madison, Wisconsin, is comprised of a team of engineers with over 200 years of combined experience in the design and development of related products.
]]>ICS Xprezz provides the revolutionary ability for clinicians to view their patients’ comprehensive monitoring information anywhere they have mobile access. Whether inside the hospital or on the go, clinicians can now have up-to-the-minute views of any waveform or numeric data captured on the XPREZZON monitor, in the palm of their hand. With ICS Xprezz clinicians can have the confidence of always being near their patients, and the freedom to respond quickly from wherever they happen to be.
“ICS Xprezz provides caregivers with a wealth of patient information on their iPad”, said Nicholas Ong, President of Spacelabs Healthcare. “With ICS Xprezz we take providing care at anytime, from anywhere, to a level not possible before. We present clinicians with the information they need to care for their patients, wherever they are.”
A natural concern of healthcare providers is security of patient data. With ICS Xprezz, Protected Health Information (PHI) can remain secure because information is processed within the hospital’s secure infrastructure, and then presented to the clinician through ICS Xprezz. Patient data is never processed or saved on the iPad, due to Spacelabs’ unique architecture and design.
Spacelabs encourages all clinicians with iPads to download and experience the freedom that ICS Xprezz can provide. Experience the power of viewing your patient information with an application optimized for a touch screen mobile device.
ICS Xprezz is now available to download from the Apple® App Store. To download, follow this link: http://itunes.apple.com/us/artist/spacelabs-healthcare-llc/id434433928?uo=4
“The future of connecting caregivers with patient information starts here,” said Nicholas Ong, President of Spacelabs Healthcare. “The XPREZZON patient monitoring solution is the beginning of a new platform of monitoring solutions from Spacelabs Healthcare. XPREZZON expands upon our rich history and expertise in connectivity to provide caregivers with quick and complete access to critical information, anywhere and anytime they have mobile access. XPREZZON also supports our customers’ prior investments through full compatibility and connectivity to our existing Ultraview SL Patient Monitors and ICS G2 Clinical Access Suite.”
XPREZZON provides clinicians with more advanced features and tools to enhance patient care. For instance, visually rich custom trends can be accessed with a single touch, or they can be displayed continuously to enable faster and better informed patient assessment. Also, highly visible alarm lights illuminating front and back aid the caregiver’s ability to identify which monitor is alarming in the busy care area. In addition, the sleek, frameless display makes cleaning easier in order to minimize the risk of infection.
Most importantly, XPREZZON was designed with the patient in mind. XPREZZON is the first patient monitor to be sensitive to a patient’s need for a good night’s rest, intuitively dimming its display in low ambient light. Also, its overall modern design provides an appealing and comfortable experience for both patient and family.
To learn more about XPREZZON, view the following video:
Or visit Spacelabs Healthcare in Booth 2829 at AACN 2011 NTI®, May 3-5 in Chicago.
Contact Information
Ross Garland
Email address: ross.garland@spacelabs.com
Phone number: 425-657-7200 x4000
IMV Ranks Spacelabs Healthcare Best for Overall Service Performance among Industry Peers for Second Consecutive Year and Three of the last Four Years
Issaquah, Wash., January 4, 2011—Spacelabs Healthcare, a pioneer in the field of patient monitoring, announced that the company leads the industry in overall service performance for the second straight year. The 2010 ServiceTrak™ Patient Monitoring Systems survey by market research firm IMV Ltd., found that Spacelabs Healthcare again ranks first in the industry in Overall Service Performance.
According to IMV, “Spacelabs 2010 rating for overall OEM service performance remains top ranked in the industry” and received the highest percentage of highly satisfied customers in the following key attributes: Overall OEM Service Performance, Overall Phone Support performance, Overall Depot Service Performance and Overall Service Engineer Performance.
“This ranking reflects the dedication we have to our customers,” said Joe Davin, Group President, Spacelabs Healthcare. “Spacelabs Healthcare is delighted that our service team exemplifies our customer-first philosophy.”
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
SOURCE: Spacelabs Healthcare
Spacelabs Healthcare
Steve Phillips
Vice President, Global Service
425-657-7200
Steve.Phillips@spacelabs.com
Issaquah, Wash., March 7, 2011 – Spacelabs Healthcare announced today that it has received FDA 510k clearance for Enhanced Flow Meter Visualization on its BleaseSirius Anesthesia System.
Identifying key information quickly and easily is critical to the anesthesia delivery practice and the ability to record and retrieve this data is also increasingly important. With traditional flow control for the Electronic Gas Flow Measurements, clinicians retain the current “touch & feel” they are accustomed to. The exact digital readout for each individual gas is displayed using 3D flow tubes and numerics, making for an easy to read format. Furthermore, the dedicated display is positioned where clinicians would find traditional flow tubes, allowing them to instantly know the fresh gas flow to their patient. This data is immediately available for export to a patient monitoring system or electronic medical record.
“Spacelabs Anesthesia Systems, including the new BleaseSirius, incorporate the latest technology offering clinicians unparalleled performance in ventilation and vaporization,” said Nicholas Ong, Group President, Spacelabs Healthcare. “Focusing on the patient and clinician to machine relationship has allowed us to offer clinicians integrated technology, reduced cost of ownership and clinical ease of use.”
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s BleaseSirius product. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
Source: Spacelabs Healthcare
Dante Cifuentes, Spacelabs Healthcare’s Managing Director of Latin America, said, “We take special pride in the role the élance patient monitor played in this historic rescue operation. The monitor’s ease of use, reliability and versatility served the hospital well at a critical time.”
Nicholas Ong, Group President, Spacelabs Healthcare, commented: “This is a living example of the commitment of the Spacelabs mission—connecting innovation with care, not just in this dramatic rescue story but in the everyday lives of patients around the world.”
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the company’s expectations, goals or intentions about the future, including, the Company’s contracts to deliver a broad range of solutions to customers in the healthcare industry. The actual results may differ materially from those described in or implied by any forward-looking statement.
SOURCE: Spacelabs Healthcare
Spacelabs Healthcare
Ross Garland
Vice President, Marketing
425-657-7200
Ross.Garland@spacelabs.com
Issaquah, Wash., April 23, 2010 – Spacelabs Healthcare expands its patient monitoring portfolio by introducing the Ultraview 2900 with dual display capability. Clinicians can now simply and efficiently chart and access lab results on one display, while the other display remains dedicated to their patients’ real-time physiologic waveforms and alarms. With easy and immediate access to comprehensive information at the bedside monitor, there is no expensive workstation to purchase and maintain, plus there is less opportunity for infectious organisms to travel from bedside to bedside – unlike mobile workstations.
DNATM (Dynamic Network Access™), which functions like a Citrix thin-client, is embedded in the Spacelabs monitor and enables full access to all applications installed on a hospital’s Citrix server. Consistent with Spacelabs’ commitment to open architecture, DNA operates on a non-proprietary infrastructure and no additional hardware is required. Because it’s easy to access information with DNA, clinicians can be assured of having the information needed to make critical clinical decisions as well as a convenient tool for sharing information with other caregivers – at the point-of-care.
“Our goal to improve the efficiency and accuracy of patient care is once again realized with the introduction of the SL2900. Not only does this new monitor support the needs of the highest acuity environments, but it delivers clinical information to where it’s needed most,” said Group President Nicholas Ong.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the Ultraview SL2900.The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
Issaquah, Wash., April 15, 2010 – According to MD Buyline’s April 2010 report, telemetry monitors from Spacelabs Healthcare have again earned the highest customer satisfaction rating, compared with scores from users of eight competing telemetry suppliers. In this most recent survey, Spacelabs ranks highest in all categories; System Performance, System Reliability, Installation/Implementation, Applications Training, Service Response Time and Service Repair Quality.
“The most important measure of our success is how well we serve our customers,” said Joe Davin, Group President at Spacelabs Healthcare. “Consistently achieving this top ranking clearly indicates that our continued emphasis on quality has earned the recognition of our customers.”
Spacelabs Healthcare pioneered telemetry in 1958 when tasked with monitoring the vital signs of NASA’s Gemini astronauts, and then was first to introduce telemetry to hospitals. Today, hospitals around the world depend on Spacelabs Healthcare’s telemetry for continuous, reliable monitoring of ambulatory patients.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the evaluation of the Company’s telemetry devices. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
Issaquah, Wash., April 16, 2010 – Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare’s Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.
The latest in the Ultraview series, the new DM3 can be used in any patient care environment where basic vital signs monitoring is needed. In Spot-Check mode, the DM3 supports batch collection of basic vitals for multiple patients. Supplemental patient information, such as Pain Level, Patient Position (during NIBP), Site Check, and Caregiver ID, can also be specified by the user for inclusion in the patient’s record. After collection of patient vitals has been completed, the DM3 can be connected to the network to transmit the spot-check records for one or multiple patients to the hospital’s EMR system.
In Monitoring mode, the DM3 provides continuous monitoring and alarm support for patients who require more vigilance. In those instances, such as following a procedure, short-term but constant monitoring may be necessary based on variable patient acuity.
“In keeping with Spacelabs’ tradition of connecting innovation with care, we are pleased to introduce the Ultraview DM3, a versatile and cost-effective clinical solution, as well as an exciting addition to our expanding line of monitoring and diagnostic products,” said Group President Nicholas Ong.
The Ultraview DM3 has just recently received FDA 510(k) clearance for market and sale within the United States. Plans are underway to expand marketing and sales efforts into Canada, Europe, Middle East and Africa.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the Ultraview DM3. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
Nottingham’s Children’s Hospital has benefited from new, state-of-the-art equipment that helped save the life of a six-month-old baby within hours of being installed.
The £15,000 for the Ultrasonic Cardiac Output Monitor, or USCOM, was donated to Nottingham University Hospitals Charity by Councillor Barrie Cooper, the former Mayor of Rushcliffe.
Councillor Cooper chose NUH Charity’s Children’s Hospital fund as his ‘Charity of the Year’ during his year of office in 2008-09, and raised a total of £15,439.20.
The USCOM, which provides a non-invasive way of measuring the heart function of sick children, was installed in the Paediatric Intensive Care Unit (PICU) at the Queen’s Medical Centre on January 16th.
One of the first patients to benefit from the machine was six-month-old Abbie Sisson, who was rushed to hospital on January 16th with suspected meningitis.
Her mum, Charlotte Pattison, 23, from Nottingham, explained: “Abbie just wouldn’t wake up so we called NHS Direct and they sent an ambulance and she was taken to the Queen’s Medical Centre. Then a rash started to appear.
“When she got to the hospital she was hooked up to a load of monitors and then she was taken to intensive care where we didn’t see her for two and a half hours. Then the consultant came in and said she only had a small chance of survival. There are no words to describe how we felt.”
Abbie was diagnosed with meningococcal septicaemia, the blood poisoning version of meningitis, and was given just a four per cent chance of survival.
Dr Patrick Davies, Consultant in Paediatrics, treated Abbie and used the newly-installed USCOM to help find the right treatment for her.
Dr Davies explained: “The USCOM works by measuring the speed, volume, and force of blood flow coming out of the heart, which enables us to exactly define how hard the heart is working, and which aspects of its work the heart is struggling with.
“Once we know this, we can give the patient drugs to help the heart to support the patient’s blood pressure. We have a range of drugs we can use, which all have different actions. Previously, we had to use guesswork to choose the right drug - now we can be sure of what we use.
“Abbie was extremely unwell when she arrived with us with meningococcal septicaemia and was probably within minutes of a cardiac arrest. On admission, her percentage chance of death was calculated at 96%. Use of the USCOM machine helped us define the best treatment for her, and to make sure we had the right dose of the right drug at the right time.
“Abbie responded excellently to treatment and knowledge of exactly what was happening with her heart was an integral part of her treatment. We obviously don’t know what would have happened without the machine, but the more we know about these patients, the better.”
Mum Charlotte said: “Abbie made it through the night and then in the morning the consultant said he was amazed she had made such a good recovery so quickly.”
Abbie made a full recovery and is now back home with Charlotte, who said: “You would never know now that she was so ill – she’s giggling and really happy and absolutely perfect. The staff in the ward were absolutely amazing. The consultant, Dr Patrick Davies, was so fantastic – he has done so much for our family.”
Councillor Cooper visited PICU and met with Charlotte and Abbie after the baby’s recovery. Explaining why he chose to raise funds for the Children’s Hospital, he said: “I had lots of requests from lots of different charities and it was difficult choose but we thought we would like to do something for children so that’s when I got in contact with the hospitals charity.
“We were invited to visit the QMC and saw some of the children in the wards and that made our mind up.”
Fundraising events run by Councillor Cooper included concerts, lunches and a quiz night.
Nottingham University Hospitals Charity exists to support the work that takes place at Nottingham University Hospitals (NUH) Queen’s Medical Centre and City Hospital campuses.
Donations to the charity are used to enhance patient care at NUH by providing specialist equipment, medical research and staff training.
To find out more about NUH Charity, to make a donation or to get involved in fundraising, go to www.nuhcharity.org.uk.
Two photographs are attached – one of Barrie Cooper and Abbie Sisson, the other, from left to right, shows Charlotte Pattison and Adam Sisson, their daughter Abbie Sisson, Jean Cooper and her husband Barrie Cooper.
Charlotte Pattison is available for interview and photographs on request – please contact Samantha Hughes, NUH Charity Promotions Officer.
Media Contact
Samantha Hughes
Promotions Officer
Nottingham University Hospitals Charity
0115 9691169 extension 59946
Samantha.Hughes@nuh.nhs.uk
Notes
NUH Charity supports the work that goes on at Nottingham University Hospitals Queen’s Medical Centre and City Hospital campuses. Donations to the charity are used in four key areas:
The NHS provides core funding, but donations to NUH Charity really make a difference to patient experience by providing extras.
With almost £3 million in generous donations every year from all sectors of the community, NUH Charity has been able to work closely with Nottingham University Hospitals NHS Trust to provide these extras, making a significant difference to patients, their families, and staff within all areas of our Hospitals.
Last financial year, this money was used to support initiatives such as the purchase of new curtains for all clinical areas of the Trust; a youth room; a complementary therapy service for children; specialist nursing and midwifery training; an ultrasound scanner for problematic pregnancies; a number of items of equipment to assist in the treatment of Prostate Cancer and urological diseases; a robot used by researchers looking for ways to diagnose earlier breast and other cancers; staff awards ceremonies; as well as funding vital research and generally enhancing patient and staff care.
NUH Charity welcomes enquiries from the media about the appeals it runs, the generous gifts it receives and how donations are helping patients, their families and staff throughout NUH NHS Trust.
Our registered charity number is 1059049.
]]>